Hospital Quality Improvement Initiative


TMF Health Quality Institute helps hospitals participating in the Hospital Quality Improvement Initiative (HQIC) reduce all-cause patient harm and readmissions in rural, medically underserved and vulnerable populations. The Centers for Medicare & Medicaid Services has contracted with TMF to work with qualifying hospitals. Together, we will identify solutions to improve health care outcomes and improve patient care in your facility.

As a member of the HQIC network, you have access to the latest news, resources, learning opportunities and forum discussions. Your hospital and health care providers work hard every day to provide safe reliable quality care. TMF looks forward to partnering with you to improve the effectiveness, efficiency, economy and quality of services delivered to your patients. Download our fact sheet (PDF) to learn more.

These items also available in the Resource Library 
U.S. Government to Purchase 66 Million Doses of Moderna’s Variant-Specific COVID-19 Vaccine Booster for Potential Use in Fall and Winter 2022
The U.S. Department of Health and Human Services, in collaboration with the U.S. Department of Defense, has announced an agreement to purchase 66 million doses of Moderna’s bivalent COVID-19 vaccine booster candidate for potential use in the fall and winter of 2022.
HHS Expands Availability of Monkeypox Vaccine to More Than 1.1 Million Doses
The U.S. Department of Health and Human Services (HHS) announced plans to allocate an additional 786,000 doses of JYNNEOS vaccine to states and and jurisdictions. The additional vaccine allocation adds to the more than 340,000 doses of JYNNEOS vaccine that have already been delivered to jurisdictions.
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
Read this article in the New England Journal of Medicine to learn how the drugs developed to treat the virus that causes COVID-19 works, especially against the five sublineages of the SARS-CoV-2 Omicron variant.
Update for Clinicians on Testing and Treatment for Monkeypox
The Centers for Disease Control and Prevention (CDC), and state and local public health partners, are reporting 4,907 cases of monkeypox in the United States across 46 states, Washington, D.C., and Puerto Rico. Clinicians are encouraged to read this health alert from the CDC to learn about commercial testing capabilities for monkeypox, collecting clinical specimens for testing for monkeypox and using TPOXX® (tecovirimat) for treating monkeypox.
COVID-19 Treatments
Information and guidance on COVID-19 treatments from the National Institutes of Health.
1 2 3 4 5Next